Compare Iris Energy Limited (IREN) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iris Energy Limited vs Oscar Health Inc — how do they compare? Iris Energy Limited trades at $35.19 (market cap $14.07B), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: Iris Energy Limited is the larger of the two by market cap, and Oscar Health Inc is trading nearer its 52-week high, Iris Energy Limited nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iris Energy Limited for 28 Days and Oscar Health Inc for 15 Days on average.
| IREN | OSCR | |
|---|---|---|
Market Cap | $14.07B | $10.22B |
Volume | 54,492,460 | 4,123,394 |
Sector | Technology | Health |
52-Week High | $76.41 | $33.81 |
52-Week Low | $29.31 | $10.85 |
Typical Hold Time | 28 Days | 15 Days |
Enterprise Value | $16.02B | $6.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IREN is trading at $35.71, down 7.7% over 24 hours, reflecting ongoing investor concerns despite strong analyst support. The stock shows bearish technical signals with negative earnings trends, having missed EPS expectations for three consecutive quarters. However, the company maintains robust revenue growth projections and secured significant contracts including a $9.7 billion Microsoft deal, positioning it for potential long-term AI infrastructure growth.
While IREN faces execution risks with negative profit margins and high valuation multiples, Wall Street remains overwhelmingly bullish with an $81 consensus price target representing 127% upside. The key investment thesis hinges on successful execution of AI infrastructure expansion, but investors must weigh substantial capital expenditure requirements against the company's ambitious revenue growth projections through 2030.
OSCR trades at $33.10, up 0.58% with a bullish technical signal and strong institutional support. Recent earnings show volatility with Q1 and Q2 2026 beats but a Q4 2025 miss. Revenue grew from $11.7B in 2025 to $15.3B in 2026, with net income turning positive at $551M. Analyst consensus is mixed with 30.77% buy ratings and a $34.00 price target, slightly above current levels.
The outlook is cautiously optimistic with strong revenue growth and profitability improvements, though risks include medical cost pressures and competitive ACA market dynamics. Upside potential exists if margin expansion continues, but investors should monitor execution against guidance and healthcare sector headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Iris Energy Limited
Iris Energy is a next-generation data center company that powers Bitcoin mining and AI workloads using 100% renewable energy. It focuses on building sustainable infrastructure for the global digital economy.
Read more on IREN →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
